Go Back   NeuroTalk Support Groups > >

Parkinson's Disease Tulip

New pharmacokinetics and biomarker data from the Georgetown Nilotinib trial

Reply
 
Thread Tools Display Modes
Old 03-13-2019, 01:47 PM   #1
Tupelo3
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 826
Default New pharmacokinetics and biomarker data from the Georgetown Nilotinib trial

Georgetown released some new pharmacokinetics and other biomarker data in a new report. Keep in mind it was just signal dose on small sample. I didn’t see anything groundbreaking here.

BPS Publications
Tupelo3 is offline   Reply With Quote
"Thanks for this!" says:
eds195 (03-14-2019), jeffreyn (03-13-2019), lab rat (03-15-2019), soccertese (03-16-2019)
Old 03-14-2019, 09:49 AM   #2
ashleyk
Member
 
Join Date: Oct 2006
Location: New England
Posts: 215
Default ?

I did a quick read on this. Did I miss anything on patient symptoms improving?
ashleyk is offline   Reply With Quote
Old 03-14-2019, 10:29 AM   #3
zanpar321
Member
 
Join Date: Feb 2014
Posts: 362
Default

Quote:
Originally Posted by Tupelo3 View Post
Georgetown released some new pharmacokinetics and other biomarker data in a new report. Keep in mind it was just signal dose on small sample. I didn’t see anything groundbreaking here.

BPS Publications
Some more data but what a waste of a study. I can't see how much can be learned from a single dose. No discussion of how this moved any up the road to approval/validation as a useful drug.
zanpar321 is offline   Reply With Quote
Old 03-14-2019, 02:06 PM   #4
Tupelo3
Member
 
Join Date: Mar 2013
Location: New Jersey
Posts: 826
Default

Quote:
Originally Posted by ashleyk View Post
I did a quick read on this. Did I miss anything on patient symptoms improving?
This was just pharmacokinetics and biomarker data analysis. We’re all still waiting for primary and secondary objective results which would give indications about efficacy. Some of the reported results in this article were very strange.
Tupelo3 is offline   Reply With Quote
"Thanks for this!" says:
zanpar321 (03-15-2019)
Reply

Tags
biomarker, data, georgetown, pharmacokinetics, sample

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Recruitment has begun for the Georgetown University "PD Nilotinib" phase 2 trial jeffreyn Parkinson's Disease 3 02-26-2017 06:05 PM
Georgetown Clinical Trial of Nilotinib in Alzheimer’s Disease Begins Tupelo3 Parkinson's Disease 0 01-24-2017 12:11 PM
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parki badboy99 Parkinson's Disease 1 11-05-2016 02:02 AM
Georgetown Receives FDA Clearance for Trial with Nilotinib in Alzheim zanpar321 Parkinson's Disease 10 10-07-2016 08:46 PM
Six month follow up on Nilotinib trial. Betsy859 Parkinson's Disease 30 07-17-2016 05:52 PM


All times are GMT -5. The time now is 03:49 PM.
Brought to you by the fine folks who publish mental health and psychology information at Psych CentralMental Health Forums

The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider. Always consult your doctor before trying anything you read here.


Powered by vBulletin • Copyright ©2000 - 2019, Jelsoft Enterprises Ltd.
Search Engine Optimisation provided by DragonByte SEO v2.0.31 (Lite) - vBulletin Mods & Addons Copyright © 2019 DragonByte Technologies Ltd.

All posts copyright their original authors • Community GuidelinesTerms of UsePrivacy Policy